DrugDashboards

Market view

desloratadine

37 marketed package NDCs · 20 active manufacturers

Most dispensed: 5 mg · Tablet, Film Coated · #100 tablet, film coateds/bottle · 5 mg · Tablet · #100 tablets/bottle, plastic · 5 mg · Tablet · #500 tablets/bottle, plastic · 5 mg · Tablet, Film Coated · #500 tablet, film coateds/bottle

The short version

20 companies supply this market — deep enough that no single failure threatens the supply. The generic price is down 14% over the past year, to $0.2553 per unit. The brand runs $8.85 per unit 35× more.

Price range and competition

RSS: changes for this drug
priced separately — they are not the same market

Generic products only. Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$2.00$4.00Nov 2013Sep 2026020companies actively selling

Latest · Sep 2026 — typical price $0.2553 · middle half $0.2553$1.39 · full range $0.2553$4.79 · 8 products · 20 companies

middle half of companies’ pricestypical (median) pricewhat manufacturers charge wholesalers (WAMP)companies actively selling (bottom lane)Priced per unitSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for desloratadine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • DesloratadineAug 28, 2026
    Mfr entered
    Morepen Bio Inc. · desloratadine
  • DesloratadineAug 28, 2026
    New product
    Morepen Bio Inc.
  • DesloratadineAug 28, 2026
    New product
    Morepen Bio Inc.
  • DesloratadineAug 19, 2026
    Price down
    NADAC $0.26149 → $0.25526 per unit (-2.38%)
  • DesloratadineAug 19, 2026
    Price down
    NADAC $0.26149 → $0.25526 per unit (-2.38%)
  • DesloratadineAug 19, 2026
    Price down
    NADAC $0.26149 → $0.25526 per unit (-2.38%)
  • DesloratadineAug 19, 2026
    Price down
    NADAC $0.26149 → $0.25526 per unit (-2.38%)
  • DesloratadineAug 19, 2026
    Price down
    NADAC $0.26149 → $0.25526 per unit (-2.38%)
  • DesloratadineAug 19, 2026
    Price down
    NADAC $0.26149 → $0.25526 per unit (-2.38%)
  • DesloratadineAug 19, 2026
    Price up
    NADAC $4.7821 → $4.78821 per unit (+0.13%)

Same drug class

Other molecules FDA puts in Histamine-1 Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Desloratadine in shortage right now?
No. FDA does not currently list Desloratadine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Desloratadine?
20 companies have marketed Desloratadine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Desloratadine cost?
The typical pharmacy pays about $0.2553 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.